ibandronic acid has been researched along with Dermatitis Medicamentosa in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Y; Song, X; Zhao, H | 1 |
| Barrantes-González, M; Espona-Quer, M; Giménez-Arnau, AM; Salas, E | 1 |
2 other study(ies) available for ibandronic acid and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Erythema multiforme caused by ibandronate sodium: A rare case report.
Topics: Bone Density Conservation Agents; Drug Eruptions; Erythema Multiforme; Female; Humans; Ibandronic Acid; Middle Aged; Osteoporosis | 2019 |
Bisphosphonate-induced cutaneous adverse events: the difficulty of assessing imputability through patch testing.
Topics: Aged; Alendronate; Case-Control Studies; Diphosphonates; Drug Eruptions; Female; Humans; Ibandronic Acid; Male; Patch Tests; Reference Values; Retrospective Studies; Sampling Studies; Sensitivity and Specificity; Severity of Illness Index | 2014 |